Citi upgrades Hims & Hers Health (HIMS.US) rating to "Neutral", optimistic about compliance premium under Novo Nordisk agreement
Show original
This adjustment is mainly based on a key agreement recently reached between the company and Novo Nordisk (NVO.US): by acting as an agent to sell Novo Nordisk's GLP-1 drugs for weight loss and type 2 diabetes treatment, Hims & Hers Health has significantly reduced a variety of business risks previously concerning the market, including core issues such as product pipeline singularity, market competition pressure, and compliance uncertainties.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Swing whale "pension-usdt.eth" starts going long on crude oil, with an average entry price of $86.73
BlockBeats•2026/03/10 14:14
Swing whale "pension-usdt.eth" starts going long on crude oil, with an average entry price of $86.73
BlockBeats•2026/03/10 14:14
Bitcoin exchange balances hit all-time low
AIcoin•2026/03/10 14:13
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$69,542.35
+1.07%
Ethereum
ETH
$2,015.58
+0.05%
Tether USDt
USDT
$1
+0.02%
BNB
BNB
$639.85
+0.96%
XRP
XRP
$1.39
+1.83%
USDC
USDC
$1
+0.00%
Solana
SOL
$85.41
+0.83%
TRON
TRX
$0.2840
-0.25%
Dogecoin
DOGE
$0.09573
+5.03%
Cardano
ADA
$0.2620
+1.76%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now